Combining incretin-based drugs and RAAS inhibitors: more cons than pros?

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)684-685
JournalLancet diabetes & endocrinology
Volume2
Issue number9
DOIs
Publication statusPublished - 2014

Cite this